STREPSILS WITH VITAMIN C 0.6/1.2/100 Milligram Lozenges

País: Irlanda

Idioma: anglès

Font: HPRA (Health Products Regulatory Authority)

Compra'l ara

Descargar Fitxa tècnica (SPC)
22-04-2017

ingredients actius:

AMYLMETACRESOL, 2, 4-DICHLOROBENZYL ALCOHOL, ASCORBIC ACID

Disponible des:

Reckitt Benckiser Ireland Ltd

Codi ATC:

R02AA03

Designació comuna internacional (DCI):

AMYLMETACRESOL, 2, 4-DICHLOROBENZYL ALCOHOL, ASCORBIC ACID

Dosis:

0.6/1.2/100 Milligram

formulario farmacéutico:

Lozenges

tipo de receta:

Product not subject to medical prescription

Área terapéutica:

Antiseptics

Estat d'Autorització:

Authorised

Data d'autorització:

2013-07-19

Fitxa tècnica

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Strepsils with Vitamin C Lozenges
Amylmetacresol 0.6mg
2,4-Dichlorobenzyl Alcohol 1.2mg
Vitamin C 100mg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each lozenge contains 0.6 mg Amylmetacresol, 1.2 mg 2,
4-Dichlorobenzyl Alcohol and 100 mg Vitamin C (as
Ascorbic Acid and Sodium Ascorbate).
Excipients: Each lozenge also contains 968.5 mg glucose, 1437.9 mg
sucrose, 0.162 mg sunset yellow FCF (E110) and
0.016 mg Ponceau 4R (E124).
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Lozenge
An orange flavoured and coloured circular lozenge. Embossed on both
sides with strepsils brand icon.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For the symptomatic relief of mouth and throat infection.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY
The lowest effective dose should be used for the shortest duration
necessary to relieve symptoms up. It is recommended
that the product should be used for a maximum of 3 days.
Adults:
One lozenge every 2-3 hours. Do not take more than 12 lozenges in 24
hours.
Paediatric population - Children over 6 years of age:
As above for adults
Children under 6 years of age:
Not suitable for children under 6 years (see section 4.4)
Elderly:
There is no need for dosage reduction in the elderly.
Method of administration:
For oromucosal administration.
To be dissolved slowly in the mouth.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_7_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_7_
_
                                
                                Llegiu el document complet